Cargando…
Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Glucocorticoids are widely used as an ophthalmic medication. A common, sight-threatening adverse event of glucocorticoid usage is ocular hypertension, caused by dysfunction of the conventional outflow pathway. We report that netarsudil, a rho-kinase inhibitor, decreased glucocorticoid-induced ocular...
Autores principales: | Li, Guorong, Lee, Chanyoung, Read, A Thomas, Wang, Ke, Ha, Jungmin, Kuhn, Megan, Navarro, Iris, Cui, Jenny, Young, Katherine, Gorijavolu, Rahul, Sulchek, Todd, Kopczynski, Casey, Farsiu, Sina, Samples, John, Challa, Pratap, Ethier, C Ross, Stamer, W Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009676/ https://www.ncbi.nlm.nih.gov/pubmed/33783352 http://dx.doi.org/10.7554/eLife.60831 |
Ejemplares similares
-
The relationship between outflow resistance and trabecular meshwork stiffness in mice
por: Wang, Ke, et al.
Publicado: (2018) -
Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
por: Ren, Ruiyi, et al.
Publicado: (2016) -
In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
por: Li, Guorong, et al.
Publicado: (2019) -
Trabodenoson, an Adenosine Mimetic With A(1) Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice
por: Li, Guorong, et al.
Publicado: (2018) -
VEGF as a Paracrine Regulator of Conventional Outflow Facility
por: Reina-Torres, Ester, et al.
Publicado: (2017)